2022 Honda Accord Touring
2.0 L • I4 • 252 hp • FWD • AT
1HGCV2F97NA010740
Sales history: 1
• $14,000Highlights
Condition
Engine starts
Seller
Insurance • GEICO
Key included
Yes
Docs
Good
History
1 record
Drive
2.0 L • I4 • 252 hp • FWD • AT
Odometer
28,056 mi ≈ 45,152 km
Primary damage
Stripped
Docs
NJ • Salvage
Extra
Auction
VIN
1HGCV2F97NA010740
Lot number
66838115
Copart
Sale status
Sold
Seller type
Insurance
Seller
GEICO
Location
Glassboro East, NJ
Description
Fuel type
Gasoline
Body color
White
Body type
Sedan
Trim
Touring
All sales final. Always run reports before bid
Sharing our own experience
Over the years, we’ve learned all the ins and outs of car importing — so you don’t have to.
How it works
A full step-by-step guide that walks you through the entire process — from signing up to receiving your car at your doorstep. Clear & beginner-friendly.
Purchase process
Knowledge base
A structured library of content covering every major topic in car importing — including terms, rules, key concepts, and important real-world nuances.
Import encyclopedia
Watch & learn
Short, practical videos packed with tips from real experience. No fluff, no theory — just what actually helps when importing a car from the US to Poland.
Watch guides
Popular Honda models
2022 Honda Accord Touring • 2.0 L • I4 • 252 hp • FWD • Automatic • Copart Lot: 66838115 • VIN: 1HGCV2F97NA010740
Find out more about this 2022 Honda Accord Touring, available at the Copart salvage car auction as lot 66838115 in Glassboro East, NJ. This car has Stripped main damage. It is listed with Engine starts start condition code. Odometer shows 28,056 mi. This White Honda Accord Sedan is equipped with Gasoline 2.0 L engine, FWD drivetrain, Automatic transmission. Check the vehicle history report for 1HGCV2F97NA010740 to access detailed information on accidents, ownership, and title status. Review pricing trends and uncover hidden issues before placing your bid.
We use cookies to improve your experience and analyze site usage, as outlined in our Privacy policy. By closing this message or continuing to browse, you consent to their use.
